Avalo Therapeutics, Inc. (AVTX): SCHEDULE 13G/A filed Aug 14, 2026

Form type

SCHEDULE 13G/A

Filing date

Aug 14, 2026

Accession number

0000921895-26-002164

Filer

Avalo Therapeutics, Inc. (CIK 1534120)